Inventor · disambiguated record
Grayson B. Lipford
Also filed as: LIPFORD GRAYSON · LIPFORD GRAYSON B
25 granted patents·35 pending applications·985 citations·filing 1998–2023
97Inventor score
Files withCOLEY PHARM GMBH13SELECTA BIOSCIENCES INC12LIPFORD GRAYSON B8ILYINSKII PETR5COLEY PHARM GROUP INC4
Top patents by PatentIndex Score
60 records- 0197US9353115B2Immune system modulatorsLIPFORD GRAYSON B·Filed 2012·Granted May 31, 2016·34 cites·19 claims
- 0296US9764031B2Dose selection of adjuvanted synthetic nanocarriersSELECTA BIOSCIENCES INC·Filed 2015·Granted Sep 19, 2017·35 cites·18 claims
- 0396US9126996B2Immune system modulatorsLIPFORD GRAYSON B·Filed 2014·Granted Sep 8, 2015·33 cites·30 claims
- 0495US9884112B2Immunomodulatory agent-polymeric compoundsSELECTA BIOSCIENCES INC·Filed 2015·Granted Feb 6, 2018·22 cites·36 claims
- 0595US9006254B2Immunomodulatory agent-polymeric compoundsSELECTA BIOSCIENCES INC·Filed 2013·Granted Apr 14, 2015·33 cites·27 claims
- 0695US7410975B2Small molecule toll-like receptor (TLR) antagonistsCOLEY PHARM GROUP INC·Filed 2004·Granted Aug 12, 2008·110 cites·9 claims
- 0795US7001890B1Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccinationCOLEY PHARM GMBH·Filed 1998·Granted Feb 21, 2006·315 cites·34 claims
- 0895US6943240B2Nucleic acids for high throughput screening of CpG-based immuno-agonist/antagonistCOLEY PHARMACEUTICALS GMBH·Filed 2001·Granted Sep 13, 2005·133 cites·7 claims
- 0994US9265815B2Tolerogenic synthetic nanocarriersFRASER CHRISTOPHER·Filed 2012·Granted Feb 23, 2016·50 cites·10 claims
- 1094US8629151B2Immunomodulatory agent-polymeric compoundsZEPP CHARLES·Filed 2010·Granted Jan 14, 2014·42 cites·19 claims
- 1194US8304396B2Immunostimulatory nucleic acidsKRIEG ARTHUR M·Filed 2006·Granted Nov 6, 2012·38 cites·9 claims
- 1292US11717569B2Tolerogenic synthetic nanocarriersSELECTA BIOSCIENCES INC·Filed 2016·Granted Aug 8, 2023·5 cites·19 claims
- 1392US9066978B2Dose selection of adjuvanted synthetic nanocarriersILYINSKII PETR·Filed 2011·Granted Jun 30, 2015·35 cites·11 claims
- 1492US7820379B2Process for high throughput screening of CpG-based immuno-agonist/antagonistCOLEY PHARM GMBH·Filed 2005·Granted Oct 26, 2010·19 cites·20 claims
- 1590US8283328B2Immunostimulatory nucleic acidsKRIEG ARTHUR M·Filed 2003·Granted Oct 9, 2012·40 cites·11 claims
- 1686US9873694B2Imidazole quinoline-based immune system modulatorsJANUS BIOTHERAPEUTICS INC·Filed 2012·Granted Jan 23, 2018·12 cites·20 claims
- 1786US2024156955A1Tolerogenic synthetic nanocarriersSELECTA BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1882US8658607B2Immunostimulatory G, U-containing oligoribonucleotidesLIPFORD GRAYSON B·Filed 2006·Granted Feb 25, 2014·4 cites·8 claims
- 1980US8546550B2Immunostimulatory oligonucleotidesLIPFORD GRAYSON B·Filed 2011·Granted Oct 1, 2013·5 cites·27 claims
- 2079US9637489B2Immune system modulatorsJANUS BIOTHERAPEUTICS INC·Filed 2015·Granted May 2, 2017·2 cites·30 claims
- 2178US8354522B2Immunostimulatory oligoribonucleotidesCOLEY PHARM GMBH·Filed 2011·Granted Jan 15, 2013·3 cites·12 claims
- 2278US8153141B2Immunostimulatory G, U-containing oligoribonucleotidesLIPFORD GRAYSON·Filed 2003·Granted Apr 10, 2012·12 cites·31 claims
- 2373US7662949B2Immunostimulatory oligoribonucleotidesCOLEY PHARM GMBH·Filed 2006·Granted Feb 16, 2010·1 cites·14 claims
- 2472US9359361B2Immune system modulatorsLIPFORD GRAYSON B·Filed 2012·Granted Jun 7, 2016·1 cites·22 claims
- 2570US2007184465A1Methods for regulating hematopoiesis using CpG-oligonucleotidesCOLEY PHARM GMBH·Filed 2006·Application pending·0 cites
- 2670US2020390881A1Nanocarriers possessing components with different rates of releaseSELECTA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2767US9428536B2Immunostimulatory G, U-containing oligoribonucleotidesZOETIS BELGIUM SA·Filed 2014·Granted Aug 30, 2016·1 cites·7 claims
- 2866US2004235778A1Methods for regulating hematopoiesis using CpG-oligonucleotidesCOLEY PHARM GMBH·Filed 2004·Application pending·0 cites
- 2966US2004234512A1Methods for regualting hematopoiesis using CpG-oligonucleotidesCOLEY PHARM GMBH·Filed 2004·Application pending·0 cites
- 3066US2004235777A1Methods for regulating hematopoiesis using CpG-oligonucleotidesCOLEY PHARM GMBH·Filed 2004·Application pending·0 cites
- 3164US2018256709A1Immunomodulatory agent-polymeric compoundsSELECTA BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 3264US2010316659A1Immunostimulatory oligoribonucleotidesCOLEY PHARM GMBH·Filed 2009·Application pending·0 cites
- 3363US2014242173A1Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agentsSELECTA BIOSCIENCES INC·Filed 2014·Application pending·0 cites
- 3462US2014030344A1Targeted synthetic nanocarriers with ph sensitive release of immunostimulatory agentsSELECTA BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 3562US2004030118A1Methods for regulating hematopoiesis using CpG-oligonucleotidesFiled 2003·Application pending·0 cites
- 3657US10117875B2Immune system modulatorsJANUS BIOTHERAPEUTICS INC·Filed 2017·Granted Nov 6, 2018·0 cites·28 claims
- 3757US2010160314A1Small Molecule Inhibitors of Toll-Like Receptor 9LIPFORD GRAYSON B·Filed 2007·Application pending·0 cites
- 3856US2012058153A1Synthetic nanocarrier vaccines comprising proteins obtained or derived from human influenza a virus hemagglutininILYINSKII PETR·Filed 2011·Application pending·0 cites
- 3955US2017349433A1Immunonanotherapeutics providing a th1-biased responseLIPFORD GRAYSON B·Filed 2017·Application pending·0 cites
- 4055US2005100983A1Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signalingUNIV MUENCHEN TECH·Filed 2004·Application pending·0 cites
- 4155US2012064110A1Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutininILYINSKII PETR·Filed 2011·Application pending·0 cites
- 4254US2005215501A1Methods and products for enhancing epitope spreadingCOLEY PHARM GROUP INC·Filed 2004·Application pending·0 cites
- 4353US2009060927A1Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccinationCOLEY PHARM GMBH·Filed 2004·Application pending·0 cites
- 4453US2006241076A1Modified oligoribonucleotide analogs with enhanced immunostimulatory activityCOLEY PHARM GROUP INC·Filed 2006·Application pending·0 cites
- 4553US2005054601A1Pharmaceutical composition comprising a polynucleotide and optionally an antigen especially for vaccinationCOLEY PHARM GMBH·Filed 2004·Application pending·0 cites
- 4652US2007232622A1Small molecule toll-like receptor (TLR) antagonistsCOLEY PHARM GROUP INC·Filed 2006·Application pending·0 cites
- 4752US2012058154A1Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus m2eILYINSKII PETR·Filed 2011·Application pending·0 cites
- 4850US2018043023A1Dose selection of adjuvanted synthetic nanocarriersILYINSKII PETR·Filed 2017·Application pending·0 cites
- 4950US2003166001A1Toll-like receptor 3 signaling agonists and antagonistsFiled 2002·Application pending·0 cites
- 5047US2005256073A1Immunostimulatory viral RNA oligonucleotidesCOLEY PHARM GMBH·Filed 2005·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Grayson B. Lipford files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →